Accuronix Therapeutics

About:

Accuronix Therapeutics is a biotech company that develops drug targeting technology to resolve issues in cancer therapy.

Website: http://accuronix.com/

Top Investors: BioGenerator, Missouri Technology Corporation

Description:

We are applying a novel drug-targeting technology to some of the most difficult problems in cancer therapy.

Total Funding Amount:

$625000

Estimated Revenue Range:

Less than $1M

Headquarters Location:

St Louis, Missouri, United States

Founded Date:

2015-01-01

Founders:

Robert Mach, William Hawkins

Number of Employees:

1-10

Last Funding Date:

2016-01-28

IPO Status:

Private

Industries: